Oncology Scientific Innovation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Flare Therapeutics Further Strengthens Leadership Team with Key Executive Appointments and Promotions

/PRNewswire/ Flare Therapeutics Inc., a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases,.

United kingdomNew yorkUnited statesMemorial sloan kettering cancer centerCity ofAmit rakhitTriana biomedicinesDaphne karydasJigar raythathaMichaell meyersMichaela bowdenPrnewswire flare therapeutics incJj london innovation centreAlbert einstein college of medicineNovartis institutes for biomedical research incDublin city university

Protagonist Reports Third Quarter 2022 Financial Results and Provides Corporate Update

/PRNewswire/ Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") today reported financial results for the third quarter ended September.

United statesNew orleansSutro biopharmaArturo molinaDineshv patelZealand pharmaExchange commissionExposition of the american society hematologyDevelopment rd expensesJanssen biotech incProtagonist therapeutics incChief medical officerAnnual meetingAmerican societyChief executive officerSubcutaneous injectable hepcidin mimetic

Protagonist Announces Appointment of Arturo Molina, M D , M S , F A C P as Chief Medical Officer

/PRNewswire/ Protagonist Therapeutics (Nasdaq: PTGX) ("Protagonist" or "the Company") today announced the appointment of Arturo Molina, M.D., M.S., F.A.C.P..

Stanford universityUnited statesSutro biopharmaArturo molinaDineshv patelDepartment of hematology bone marrow transplantationJanssen biotech incStanford university school of medicineUniversity of texas at austinStanford university medical centerDivision of oncologyDepartment of medicineChief medical officerChief executive officerVice presidentOncology scientific innovation

Nuvalent Appoints Michael L Meyers, MD, PhD, to Board of Directors

/PRNewswire/ Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically.

New yorkUnited statesMemorial sloan kettering cancer centerUnited kingdomMichaell meyersJames porterNuvalent incPrnewswire nuvalent incMedicine at columbia presbyterian medical centerCompany quarterly report on formUs oncology medical affairsAlbert einstein college of medicineAventis pharmaceuticals incPlough research instituteExchange commissionSyndax pharmaceuticals inc

Nuvalent Inc (NUVL) Appoints Michael L Meyers to its Board

Nuvalent Inc (NUVL) Appoints Michael L Meyers to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMemorial sloan kettering cancer centerMichaell meyersJames porterNuvalent incUs oncology medical affairsAlbert einstein college of medicineAventis pharmaceuticals incPlough research instituteSyndax pharmaceuticals incMedicine at columbia presbyterian medical centerSenior clinical advisorChief executive officerSenior vice presidentChief development officer